ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis

Table 1 IHC expression of ZNF703 in seventy-six triple-negative breast cancer patients

Characteristics	Total No.	ZNF703 Low/negative No. (%)	ZNF703 High No. (%)	P value ^b
Age	76			0.90
<=50		20 (40.0)	10 (38.5)
>50		30 (60.0)	16 (61.5)
Lymph node metastases	61 ^a			0.14
No		31 (75.6)	11 (55.0)
Yes		10 (24.4)	9 (45.0)
Grade	76			0.46
1		2 (4.0)	3 (11.5)
2		24 (48.0)	12 (46.2)
3		24 (48.0)	11 (42.3)
Pathological type	76			0.84
IDC		45 (90.0)	23 (88.5)
other		5 (10.0)	3 (11.5)
Tumor size	53 ^a
< 3 cm		15 (40.5)	8 (50.0)	0.56
>= 3 cm		22 (59.5)	8 (50.0)
Stage	60 ^a
I		9 (22.5)	3 (15.0)	0.73
II/III		31 (77.5)	17 (85.0)

^a Missing data not calculated statistically. ^b P values less than 0.05 considered statistically significant

ISSN: 1471-2407